276 related articles for article (PubMed ID: 3220223)
21. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
Kreuzer W
Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
[TBL] [Abstract][Full Text] [Related]
22. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
[TBL] [Abstract][Full Text] [Related]
23. Peritoneovenous shunting is an effective treatment for intractable ascites.
Sooriakumaran P; McAndrew HF; Kiely EM; Spitz L; Pierro A
Postgrad Med J; 2005 Apr; 81(954):259-61. PubMed ID: 15811892
[TBL] [Abstract][Full Text] [Related]
24. [Surgical approach to posthepatitic cirrhotic patient today].
Meriggi F; Forni E
G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
[TBL] [Abstract][Full Text] [Related]
25. LeVeen peritoneo-venous shunt in treatment of intractable cirrhotic ascites.
Chen YR; Chen MZ
Chin Med J (Engl); 1984 May; 97(5):376-8. PubMed ID: 6439491
[No Abstract] [Full Text] [Related]
26. Peritoneovenous shunting in intractable ascites.
Deans GT; Spence RA; Johnston GW
Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
[TBL] [Abstract][Full Text] [Related]
27. [Cost of the peritoneovenous shunt in patients with cirrhosis].
Hillaire S; Schachtel M; Kempa M; Smadja C; Grange D; Franco D
Gastroenterol Clin Biol; 1989 Nov; 13(11):901-4. PubMed ID: 2612834
[TBL] [Abstract][Full Text] [Related]
28. Peritoneovenous shunting for cirrhotic versus malignant ascites.
Kostroff KM; Ross DW; Davis JM
Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
[TBL] [Abstract][Full Text] [Related]
29. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
Castells A; Saló J; Planas R; Quer JC; Ginès A; Boix J; Ginès P; Gassull MA; Terés J; Arroyo V
Hepatology; 1994 Sep; 20(3):584-91. PubMed ID: 8076916
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
Holm A; Rutsky EA; Aldrete JS
Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
[TBL] [Abstract][Full Text] [Related]
31. Role of surgical therapy in management of intractable ascites.
Elcheroth J; Vons C; Franco D
World J Surg; 1994; 18(2):240-5. PubMed ID: 8042329
[TBL] [Abstract][Full Text] [Related]
32. Saphenous--peritoneal shunt in refractory ascites: a neglected technique.
Thapa PB; Rungta A; Joshi MR; Singh DR; Sharma SK
JNMA J Nepal Med Assoc; 2006; 45(162):258-61. PubMed ID: 17189972
[TBL] [Abstract][Full Text] [Related]
33. Peritoneovenous shunting for malignant ascites.
Wickremesekera SK; Stubbs RS
N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
[TBL] [Abstract][Full Text] [Related]
34. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
[TBL] [Abstract][Full Text] [Related]
35. Peritoneovenous shunts for malignant ascites.
Sonnenfeld T; Tydén G
Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
[TBL] [Abstract][Full Text] [Related]
36. Management of colorectal cancer in patients with cirrhosis and a LeVeen shunt.
Le Rolland B; Kahwaji F; Smadja C; Traynor O; Grange D; Franco D
Int Surg; 1987; 72(2):93-5. PubMed ID: 3610539
[TBL] [Abstract][Full Text] [Related]
37. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
38. Long term results (greater than 5 years) in patients with peritoneovenous shunting for intractable ascites: liver function and cancer mortality.
Franco D; Meakins JL; Wu A; Smadja C; Bonnet P; Gouffier E; Campillo B
HPB Surg; 1989 Oct; 1(3):185-91, discussion 191-4. PubMed ID: 2487384
[TBL] [Abstract][Full Text] [Related]
39. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
40. [Early complications and long-term results of the LeVeen peritoneo-venous shunt in the treatment of refractory ascites].
Arciero G; Di Blasio V; Botta V; Rossi M; Pigna F; Di Tora A
Minerva Chir; 1996 Nov; 51(11):897-901. PubMed ID: 9072716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
